Clinical Trial Update: Ampligen in Chronic Fatigue Syndrome

View source ↗

Summary

AIM ImmunoTech's Ampligen trial in Chronic Fatigue Syndrome has a status update indicating the study is temporarily unavailable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome

Drugs mentioned

• Ampligen (rintatolimod)

Snippet

Sponsor: AIM ImmunoTech Inc. | Conditions: Chronic Fatigue Syndrome | Status: TEMPORARILY_NOT_AVAILABLE